Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Califf

Showing results (41-50 of 567) with videos related to

Pageof 57
Sort By:
American Heart Journal|December 13, 1997
Issues of cost-effectiveness in the use of antithrombotic therapy for ischemic heart diseaseR M Califf, D B Mark
American Heart Journal|October 28, 1999
Diabetes and cardiovascular disease: current opinions and future directionsD K McGuire, R M Califf
American Heart Journal|November 30, 1999
Should the emergence of new agents change the management of patients with acute coronary syndromes without ST-segment elevation?R M Califf, D R Holmes
American Heart Journal|January 5, 2000
Cardiac protection: evolving role of angiotensin receptor blockersR M Califf, J N Cohn
American Heart Journal|April 26, 2001
International differences in cardiovascular clinical trials. IntroductionJ C O'Shea, R M Califf
American Heart Journal|April 26, 2001
International differences in treatment effects in cardiovascular clinical trialsJ C O'Shea, R M Califf
The Annals of Thoracic Surgery|February 1, 1996
A randomized study would answer the questionJ G Jollis, R M Califf
Coronary Artery Disease|May 1, 1994
The role of angioplasty after failed thrombolysis for acute myocardial infarctionR A Harrington, R M Califf
Annals of Epidemiology|January 1, 1995
The complexity of studying coronary heart disease in womenE D Peterson, R M Califf
The New England Journal of Medicine|July 2, 1992
Thrombolytic therapy for elderly patientsE J Topol, R M Califf
Pageof 57

Showing results (41-50 of 567) with videos related to

Sort By:
Pageof 57
American Heart Journal|December 13, 1997
Issues of cost-effectiveness in the use of antithrombotic therapy for ischemic heart diseaseR M Califf, D B Mark
American Heart Journal|October 28, 1999
Diabetes and cardiovascular disease: current opinions and future directionsD K McGuire, R M Califf
American Heart Journal|November 30, 1999
Should the emergence of new agents change the management of patients with acute coronary syndromes without ST-segment elevation?R M Califf, D R Holmes
American Heart Journal|January 5, 2000
Cardiac protection: evolving role of angiotensin receptor blockersR M Califf, J N Cohn
American Heart Journal|April 26, 2001
International differences in cardiovascular clinical trials. IntroductionJ C O'Shea, R M Califf
American Heart Journal|April 26, 2001
International differences in treatment effects in cardiovascular clinical trialsJ C O'Shea, R M Califf
The Annals of Thoracic Surgery|February 1, 1996
A randomized study would answer the questionJ G Jollis, R M Califf
Coronary Artery Disease|May 1, 1994
The role of angioplasty after failed thrombolysis for acute myocardial infarctionR A Harrington, R M Califf
Annals of Epidemiology|January 1, 1995
The complexity of studying coronary heart disease in womenE D Peterson, R M Califf
The New England Journal of Medicine|July 2, 1992
Thrombolytic therapy for elderly patientsE J Topol, R M Califf
Pageof 57